| Financial Year |
March 31 2023 |
| Monetary Funds |
4,071,320,181.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
80,860,035.58 |
| Advances to Suppliers |
41,555,294.10 |
| Other Receivables |
23,681,824.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,688,650,014.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
80,092,221.09 |
| Total Current Assets |
5,991,247,341.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
308,734,654.16 |
| Investment Properties |
-- |
| Fixed Assetes |
3,614,265,965.84 |
| Under-construction Projects |
483,933,451.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
678,164,240.75 |
| R&D expenses |
-- |
| Goodwill |
699,192,456.06 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
740,720,096.06 |
| Other Non-Current Assets |
95,992,164.15 |
| Sub-Total of Non-Current Assets |
6,733,176,733.35 |
| Total Assets |
12,724,424,074.36 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,621,077,779.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
387,546,632.17 |
| Taxes Payable |
403,600,039.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,566,078,209.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,701,897.11 |
| Other Current Liabilities |
24,184,871.39 |
| Sub-Total of Current Liabilities |
7,772,233,503.24 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
31,488,088.43 |
| Deferred Income Tax Liabilities |
42,052,158.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
552,718,425.43 |
| Total Liabilities |
8,324,951,928.67 |
| Paid-In Capital(Or Share Stock) |
483,971,198.00 |
| Capital Surplus |
8,265,702.00 |
| Surplus Reserve |
241,985,599.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,723,044,283.24 |
| Minority Stockholder's Interest |
1,955,169,546.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,444,302,599.54 |
| Owner's Equity（Stockholder's Equity） |
4,399,472,145.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,724,424,074.36 |
